Remove topic process-validation
article thumbnail

The Promise of Generative AI in Mitigating Bias in Continuing Medical Education

PM360

Once grants are awarded, it becomes the responsibility of education producers to create fair and balanced learning activities with perspectives from a spectrum of published evidence around the topic. They must also look at literature that refutes, or on the other hand, backs up whatever topic is being focused on.

Education 105
article thumbnail

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

GreenLight’s process from formulation of the drug substance and lipid nanoparticle to bulk drug product can be carried out in this facility. An effective scale-up and fit of GreenLight’s process to Samsung Biologics’ Songdo plant were shown in all comparability data validating with anticipated outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

KSQ and Takeda expand partnership for new tumour-intrinsic targets

Pharmaceutical Technology

This partnership will focus on the identification and validation of new targets to inform treatment developments that address resistance mechanisms in cancer patients. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Sales 52
article thumbnail

ProQuest®, part of Clarivate™, launches AI-powered research assistant

Clarivate

The rigorous approach to testing and validating results is shaping a powerful new research tool that will be integrated in ProQuest solutions across major disciplines. The rigorous approach to testing and validating results is shaping a powerful new research tool that will be integrated in ProQuest solutions across major disciplines.

article thumbnail

Ginkgo Bioworks partners with WARF for new GD2 CAR T-cell therapies

Pharmaceutical Technology

All the new GD2 CAR designs developed through the partnership will be validated via in vitro screens and in vivo murine models. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

The future of the IP legal profession: new strategies, new technologies

Clarivate

We explored these timely topics with a panel of experts, capturing their insights in a new white paper entitled “The future of the IP legal profession: Balancing the rise of artificial intelligence with human expertise.” Both shared concerns over accuracy and confidentiality as potential barriers to AI adoption for IP legal processes.

article thumbnail

KOL Identification Without KOL Mapping

pharmaphorum

Among the infinite symposia, webinars, and white papers on this topic,?“KOL KOL identification is the process of identifying those individuals with high levels of expertise and influence in a given therapeutic area; in the context of building your medical and commercial strategy.? but should also aim to validate those voices. .

Media 52